Collaboration bridges the gap


By Susan Williamson
Thursday, 30 October, 2014

As part of the announcement of their new Asia Pacific Innovation Centre, Johnson & Johnson - parent company of Janssen - will facilitate new collaborations with Australian university researchers.

One collaboration is with parasitologist Professor Alex Loukas at James Cook University in Cairns in which Janssen will provide financial support to progress work on a protein produced by hookworms that shows promise as a treatment for autoimmune and inflammatory diseases, such as inflammatory bowel disease, Crohn’s disease and asthma.

“It’s very exciting for us to have a big pharma like Janssen jump in at what is a very early stage research,” said Loukas, adding that he pitched their work to Janssen at the AusBiotech national conference last year. “This stage of research - after early discovery work but before clinical trials - can be hard to find funding for. The Asia Pacific Innovation Centre is a welcome development for it bridges that gap.”

The relatively innocuous parasitic hookworm lives in the small bowel and releases a secretion with anti-inflammatory properties that help it go unnoticed by the human immune system.

“Having a few hookworms can actually be beneficial,” said Loukas. “They can protect people against autoimmune diseases.”

After exploring the active components of the hookworm secretion, one protein became the focus of Loukas’s work.

“We identified a protein, synthesised it and showed that it had protective properties in mice models for colitis and experimentally induced asthma,” said Loukas.

The protein drives the expansion of regulatory T cells, the ‘peacekeepers’ of the immune system that reduce or balance the inflammatory response.

Further developing this protein is the focus of the collaboration with Janssen and over the next year Loukas will develop a portfolio of preclinical data, such as how best to synthesise the protein and better understanding its mechanism of action.

The Asia Pacific Innovation Centre was launched at the 2014 AusBiotech national conference. Based in Shanghai, it will be headed by J&J executive Dong Wu and will include satellite offices in Australia, Singapore and Japan

Related News

Babies of stressed mothers likely to get their teeth earlier

Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...

Customised immune cells used to fight brain cancer

Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...

Elevated blood protein levels predict mortality

Proteins that play key roles in the development of diseases such as cancer and inflammation may...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd